Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,476
in 2 filings

Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBIN HOWARD W −$30K President & CEO sold <1% of stake
  2. Zalevsky Jonathan −$13K Chief R&D Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-18 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award +28,550 228,550
2020-12-18 NORTHCOTT JOHN SVP & Chief Commercial Officer Grant or award · Stock Option +51,000 51,000
2020-12-18 Labrucherie Gil M SVP, COO & CFO Grant or award +40,000 266,973
2020-12-18 Labrucherie Gil M SVP, COO & CFO Grant or award · Stock Option +71,500 71,500
2020-12-15 Myriam Curet Director Sale −1,560 $17.82 $28K 19,240
2020-11-23 Zalevsky Jonathan Chief R&D Officer Sale −16,380 $16.40 $269K 250,317
2020-11-16 Zalevsky Jonathan Chief R&D Officer Sale −29,618 $16.93 $501K 266,697
2020-11-16 Wilson Mark Andrew SVP & General Counsel Sale −1,539 $16.93 $26K 49,850
2020-11-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −11,976 $16.93 $203K 159,757
2020-11-16 ROBIN HOWARD W President & CEO Sale −11,975 $16.93 $203K 352,043
2020-11-16 Labrucherie Gil M SVP, COO & CFO Sale −8,276 $16.93 $140K 226,973
2020-09-28 Ajer Jeffrey Robert Director Sale −3,250 $17.25 $56K 25,975
2020-09-25 CHESS ROBERT Director Sale −5,500 $17.75 $98K 280,573
2020-09-22 WHITFIELD ROY A Director Grant or award +9,100 237,350
2020-09-22 WHITFIELD ROY A Director Grant or award · Stock Option +18,200 18,200
2020-09-22 Lingnau Lutz Director Grant or award +9,100 35,800
2020-09-22 Lingnau Lutz Director Grant or award · Stock Option +18,200 18,200
2020-09-22 GREER R SCOTT Director Grant or award +9,100 185,674
2020-09-22 GREER R SCOTT Director Grant or award · Stock Option +18,200 18,200
2020-09-22 EASTHAM KARIN Director Grant or award +9,100 24,100

Page 17 of 18 · 355 trades